Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Accounts Payables (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Accounts Payables for 16 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accounts Payables fell 41.58% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2025, down 41.58%, and an annual FY2024 reading of $2.9 million, down 36.47% over the prior year.
  • Accounts Payables was $1.5 million for Q3 2025 at Rockwell Medical, up from $1.5 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $5.9 million in Q2 2023 and bottomed at $1.5 million in Q2 2025.
  • Average Accounts Payables over 5 years is $3.6 million, with a median of $3.7 million recorded in 2021.
  • The sharpest move saw Accounts Payables surged 101.46% in 2023, then crashed 60.87% in 2025.
  • Year by year, Accounts Payables stood at $3.7 million in 2021, then grew by 8.4% to $4.1 million in 2022, then grew by 11.42% to $4.5 million in 2023, then plummeted by 36.47% to $2.9 million in 2024, then plummeted by 46.92% to $1.5 million in 2025.
  • Business Quant data shows Accounts Payables for RMTI at $1.5 million in Q3 2025, $1.5 million in Q2 2025, and $1.9 million in Q1 2025.